小儿推拿辅助治疗儿童腺样体肥大痰凝气滞证25例临床观察

Clinical observation on 25 cases of pediatric adenoid hypertrophy with phlegm coagulation and qi stagnation syndrome treated with pediatric tuina as an auxiliary treatment

目的 观察小儿推拿辅助治疗儿童腺样体肥大痰凝气滞证的临床疗效。方法 选取2020年6月至2021年6月永康市妇幼保健院儿内科门诊治疗的腺样体肥大痰凝气滞证患儿50例,按照就诊顺序分为对照组和治疗组,各25例。对照组予糠酸莫米松鼻喷雾剂鼻喷,孟鲁司特钠咀嚼片口服;治疗组在对照组治疗方法的基础上给予小儿推拿治疗。2组均1个月为1个疗程,共治疗2个疗程后统计疗效。结果 对照组总有效率为76.00%(19/25),治疗组为96.00%(24/25),2组比较,差异有统计学意义(P<0.05)。治疗前2组中医证候评分比较,差异无统计学意义(P>0.05),具有可比性;治疗后2组中医证候评分均明显下降,与同组治疗前比较,差异有统计学意义(P<0.05),且治疗组下降更显著(P<0.05)。治疗前2组腺样体厚度(A)/鼻咽腔宽度(N)值比较,差异无统计学意义(P>0.05),具有可比性;治疗后2组A/N值均明显下降,与同组治疗前比较,差异有统计学意义(P<0.05),且治疗组下降更显著(P<0.05)。对照组不良反应总发生率为8.00%(2/25),治疗组为4.00%(1/25),2组比较,差异无统计学意义(P>0.05)。结论 小儿推拿辅助治疗儿童腺样体肥大痰凝气滞证,疗效显著,有利于减轻患儿临床症状,改善腺样体肥大,安全性较高,值得临床推广应用。

Objective To observe the clinical efficacy of pediatric tuina as an auxiliary treatment for pediatric adenoid hypertrophy with phlegm coagulation and qi stagnation syndrome.Methods Fifty children with adenoid hypertrophy and phlegm coagulation qi stagnation syndrome who were treated at the pediatric outpatient department of Yongkang Maternal and Child Health Hospital from June 2020 to June 2021 were selected.They were divided into a control group and a treatment group according to the order of treatment,with 25 cases in each group.The control group was given mometasone furoate nasal spray and montelukast sodium chewable tablet orally.The treatment group received pediatric tuina treatment on the basis of the control group's treatment method.Both groups were treated for one course of treatment for one month,and the efficacy was calculated after a total of two courses of treatment.Results The total effective rate of the control group was 76.00%(19/25),while that of the treatment group was 96.00%(24/25).The difference between the two groups was statistically significant(P<0.05).Before treatment,there was no statistically significant difference in the scores of traditional Chinese medicine syndromes between the two groups(P>0.05),indicating comparability.After treatment,both groups showed a significant decrease in traditional Chinese medicine syndrome scores,with a statistically significant difference compared to the same group before treatment(P<0.05),and the treatment group showed a more significant decrease(P<0.05).Before treatment,there was no statistically significant difference in the thickness(A)of adenoids/width(N)of the nasopharyngeal cavity between the two groups(P>0.05),indicating comparability.After treatment,the A/N values of both groups significantly decreased,and compared with the same group before treatment,the difference was statistically significant(P<0.05),and the decrease in the treatment group was more significant(P<0.05).The total incidence of adverse reactions in the control group was 8.00%(2/25),while in the treatment group it was 4.00%(1/25).There was no statistically significant difference between the two groups(P>0.05).Conclusion Pediatric tuina as an auxiliary treatment for children of adenoid hypertrophy with phlegm coagulation and qi stagnation syndrome has a significant therapeutic effect,which is beneficial for alleviating clinical symptoms,improving adenoid hypertrophy,and has high safety.It is worthy of clinical promotion and application.